Acquisition of resistance to apoptosis and necrosis by Bcl-xL over-expression in rat hepatoma McA-RH8994 cells

J Gastroenterol Hepatol. 1999 Jul;14(7):682-90. doi: 10.1046/j.1440-1746.1999.01935.x.

Abstract

Background: Bcl-xL is the predominant anti-apoptotic Bcl-2 family member in the liver. Suppression of cell death promotes carcinogenesis and contributes to resistance to radiation and chemotherapeutic agents.

Methods: Direct effects of Bcl-xL protein on apoptosis and necrosis were investigated in rat hepatoma cells. Rat hepatoma cell line McA-RH8994 cells were transfected with expression plasmids containing a whole coding sequence of rat bcl-xL cDNA of sense orientation. Stable transfectant cell lines expressing bcl-xL cDNA (designated as RH8994/Bcl-xL-S), or control plasmid DNA (designated as RH8994/pT) were established.

Results: Cellular amounts of Bcl-xL in RH8994/Bcl-xL-S cells were demonstrated to be more than 20-fold that of RH8994/pT and parental cells. Three independent clones of RH8994/Bcl-xL-S were isolated and their susceptibility to various cell death stimuli was compared with that of the control cells. Transforming growth factor-beta1 and tumour necrosis factor-alpha induced apoptosis dose dependently in these cells, but the 50% cytotoxicity concentrations of these factors in RH8994/Bcl-xL-S cells were more than 10-fold higher than those in RH8994/pT and parental cells. Similarly, RH8994/Bcl-xL-S cells were shown to be significantly less susceptible to necrotic cell death induced by a calcium ionophore, A23187; a mutagen, N-methyl-N'-nitro-N-nitrosoguanidine; and UV-irradiation when compared with the control cells.

Conclusions: Over-expression of Bcl-xL was shown to provide protection against apoptotic and necrotic cell death in rat hepatoma cells.

MeSH terms

  • Animals
  • Apoptosis*
  • Calcimycin / pharmacology
  • Cell Death / genetics
  • Cell Death / radiation effects
  • Gene Expression
  • Ionophores / pharmacology
  • Liver Neoplasms, Experimental / metabolism*
  • Liver Neoplasms, Experimental / pathology*
  • Methylnitronitrosoguanidine / pharmacology
  • Mutagens / pharmacology
  • Necrosis*
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Rats
  • Transfection
  • Transforming Growth Factor beta / pharmacology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology
  • Ultraviolet Rays
  • bcl-X Protein

Substances

  • Bcl2l1 protein, rat
  • Ionophores
  • Mutagens
  • Proto-Oncogene Proteins c-bcl-2
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • bcl-X Protein
  • Methylnitronitrosoguanidine
  • Calcimycin